Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;55(5):695-696.
doi: 10.1002/uog.22030.

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

M N Bekker  1 , L Henneman  2 , M V E Macville  3 , E A Sistermans  2 , R J H Galjaard  4
Affiliations
Free article
Comment

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

M N Bekker et al. Ultrasound Obstet Gynecol. 2020 May.
Free article
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Jani JC, Gil MM, Benachi A, Prefumo F, Kagan KO, Tabor A, Bilardo CM, Di Renzo GC, Nicolaides KH. Jani JC, et al. Ultrasound Obstet Gynecol. 2020 May;55(5):696-697. doi: 10.1002/uog.22032. Ultrasound Obstet Gynecol. 2020. PMID: 32356932 No abstract available.

Comment on

  • Genome-wide cfDNA testing of maternal blood.
    Jani JC, Gil MM, Benachi A, Prefumo F, Kagan KO, Tabor A, Bilardo CM, Di Renzo GC, Nicolaides KH. Jani JC, et al. Ultrasound Obstet Gynecol. 2020 Jan;55(1):13-14. doi: 10.1002/uog.21945. Ultrasound Obstet Gynecol. 2020. PMID: 31894638 No abstract available.

References

    1. Gil MM, Galeva S, Jani J, Konstantinidou L, Akolekar R, Plana MN, Nicolaides KH. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet Gynecol 2019; 53: 734-742.
    1. Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2017; 50: 302-314.
    1. Jani JC, Gil MM, Benachi A, Prefumo F, Kagan KO, Tabor A, Bilardo CM, Di Renzo GC, Nicolaides KH. Genome-wide cfDNA testing of maternal blood. Ultrasound Obstet Gynecol 2020; 55: 13-14.
    1. van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, Boter M, Diderich KEM, et al. TRIDENT-2: National Implementation of Genome-Wide Non-Invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. Am J Hum Genet 2019; 105: 1091-1101.
    1. Oepkes D, Page-Christiaens GC, Bax CJ, Bekker MN, Bilardo CM, Boon EM, Schuring-Blom GH, Coumans AB, Faas BH, Galjaard RH, Go AT, Henneman L, Macville MV, Pajkrt E, Suijkerbuijk RF, Huijsdens-van Amsterdam K, Van Opstal D, Verweij EJ, Weiss MM, Sistermans EA; and for the Dutch NIPT Consortium. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Prenat Diagn 2016; 36: 1083-1090.

Substances

LinkOut - more resources